Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Bullboard (TSX:CSCI)

View:
Comment by prophetoffactzon Nov 21, 2024 1:04pm

RE:RE:Email Response from Gilles Gagnon on March 12, 2024

Gilles actually knows the cards the company is holding better than anyone. If he's convinces that can be a great sign. We've never seen the data for the pill or the discussions with potential ...more  
Comment by Ciaoon Nov 21, 2024 12:30pm

RE:RE:Email Response from Gilles Gagnon on March 12, 2024

Gilles has proven himself that he can't execute a business plan even if he had a legitimate one. I've chronicled his failures over the years. He is just incompetent. A change in leadership a ...more  
Comment by Stinzoon Nov 21, 2024 12:06pm

RE:Email Response from Gilles Gagnon on March 12, 2024

I dont know Oats, seems very arrogant to me especially with no track record and no positive momentum for years, 10+ years that is.  we are unfortunately stuck until something gives I guess ...more  
Post by oatson Nov 21, 2024 10:48am

Email Response from Gilles Gagnon on March 12, 2024

Below is the response that Gilles Gagnon provided on March 12, 2024 with regards to my message to him regarding the Merger: Hi XXXXXX, While I read that you will never forgive me and the board for ...more  
Comment by oatson Nov 21, 2024 9:34am

RE:RE:RE:RE:RE:Email to Gilles Gagnon on March 7, 2024

Stinzo, I do see value here simply based on the cash, my estimate, which I think is quite accurate is that they should have no less that $22.5 million US in cash.  This equates to about $6 per ...more  
Post by Jonathon Brownon Nov 21, 2024 6:55am

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

Comment by Stinzoon Nov 21, 2024 6:21am

RE:RE:RE:RE:Email to Gilles Gagnon on March 7, 2024

Thank you very much Oats for the background.  Even if you had not shared, i think most long term shareholders would have come to a similar conclusion.  Very sad, for all the lost money ...more  
Post by prophetoffactzon Nov 20, 2024 8:15pm

Avenanthramide

What happened to avenanthramide sales? One possibility is that the amount if avenanthramide was changed after the spin-off from J&J. This could create an opportunity for Juvente. Perplexity Ai ...more  
Comment by Ciaoon Nov 20, 2024 7:29pm

RE:RE:RE:Email to Gilles Gagnon on March 7, 2024

Oats, we were told prior to any "merger" activtiy that Ceapro had adequate funds to prioritize it's projects with cash on hand. If AV sales which we said to rebound did occur then cash ...more  
Comment by oatson Nov 20, 2024 7:04pm

RE:RE:Email to Gilles Gagnon on March 7, 2024

That is easy Ciao. They pissed away so much money on legal fees prior to announcing the deal, lower sales, and initiative $$ requirements were decimating the cash level of the company.  Based on ...more  
Comment by Ciaoon Nov 20, 2024 6:19pm

RE:Email to Gilles Gagnon on March 7, 2024

Oats, thanks for sharing your thoughts in this email to Gilles. I'll let you decide if you want to share any details for your statement with regards to the merger "You forced the hand of my ...more  
Post by oatson Nov 20, 2024 5:42pm

Email to Gilles Gagnon on March 7, 2024

If you are interested in my exact thoughts on the Merger, please see below for the message sent to Gilles on March 7, 2024.  I will post the response that I got tomorrow. Hi Gilles,   As ...more  
Comment by Tencentson Nov 20, 2024 7:36am

RE:RE:RE:RE:RE:RE:RE:RE:RE:Cash

Yes that was in 02/2021 where they also forecasted 2 market launches within 18 months  as well as estimating the immune booster market would see 40  % annuel increase until  2030 due to ...more  
Comment by prophetoffactzon Nov 19, 2024 5:52pm

RE:RE:RE:RE:RE:RE:RE:RE:Cash

They've provided a net present value analysis previously for a 40 million dose immune booster plant.
Comment by Stinzoon Nov 19, 2024 2:51pm

RE:RE:RE:RE:RE:RE:RE:RE:Cash

I was going to say the same thing ... complete a 2 year merger with no planning ...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities